Zacks.com on MSN3 天
AstraZeneca's Combination Therapy Meets Goal in Prostate Cancer Study
AstraZeneca AZN has announced positive results from the phase III CAPItello-281 study, which evaluated a combination regimen ...
阿思達克財經網4 天
阿斯利康(AZN.US)联合疗法Truqap组合3期试验结果积极
智通财经APP获悉，阿斯利康 (AZN.US) 今日宣布CAPItello-281临床3期试验的积极结果。分析显示，对于PTEN缺陷型转移性激素敏感性前列腺癌 (mHSPC)患者，阿斯利康的Truqap (capivasertib)联合阿比特龙 ...
AstraZeneca announces results from CAPItello-281 trial
Results from the CAPItello-281 Phase III trial showed that AstraZeneca’s (AZN) Truqap in combination with abiraterone and androgen deprivation ...
AstraZeneca’s Truqap combo demonstrated statistically significant improvement
High-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s (AZN) Truqap in combination with abiraterone and androgen ...